Skip to main content

Table 1 The relationship between miR-200a expression and clinicopathologic parameters in patients with breast cancer received preoperative chemotherapy

From: MicroRNA-200a confers chemoresistance by antagonizing TP53INP1 and YAP1 in human breast cancer

Clinicopathologic parameters Number of cases Median expression of miR-200a (normalized CT)a P
Age,y    0.731
  ≤ 40 13 10.60 ± 2.870  
  > 40 59 10.36 ± 2.939  
Histological type    0.892
 DCIS 3 10.63 ± 1.572  
 IDC 69 10.39 ± 2.959  
Menstrual status    0.272
 Menstrual 38 10.05 ± 2.514  
 Menopause 34 10.81 ± 3.285  
TNM stage    0.918
 II 28 10.45 ± 3.601  
 III 44 10.38 ± 2.412  
Tumor size    0.839
 T1 + T2 32 10.48 ± 2.639  
 T3 + T4 40 10.34 ± 3.138  
Chemotherapy response    0.0021
 PD + SD 22 8.958 ± 2.586  
 PR 50 11.04 ± 2.835  
ER    0.277
 Negative 27 9.920 ± 2.648  
 Positive 45 10.69 ± 3.045  
PR    0.501
 Negative 23 10.06 ± 2.166  
 Positive 49 10.56 ± 3.206  
Her2    0.515
 Negative 52 10.54 ± 3.049  
 Positive 20 10.04 ± 2.541  
All cases 72 10.40 ± 2.908  
  1. a normalized CT = CT miR-200a – CT U6